文献速递神经技术与安全MR

利用影像组学与临床特征融合提高出血性脑转移瘤与非肿瘤性血肿的鉴别

Improving differentiation of hemorrhagic brain metastases from non-neoplastic hematomas using radiomics and clinical feature fusion.
PubMed 文献 · Neuroradiology · 2025-03-25

本研究基于两家临床机构146例经病理或临床证实的出血性脑转移瘤被血肿覆盖(HBM.cbh,n=55)与非肿瘤性颅内血肿(nn-ICH,n=91)患者数据,提取T2WI、T1WI、FLAIR和T1增强多序列MRI影像组学特征并结合临床-影像学特征构建融合模型。四序列全区域影像组学模型AUC为0.84(SMOTE)和0.83(无SMOTE),临床模型AUC为0.71(SMOTE)和0.62(无SMOTE),融合模型AUC达0.93(SMOTE)和0.90(无SMOTE),优于影像组学和临床模型(p<0.05)。结论认为多序列影像组学模型可有效鉴别HBM.cbh与nn-ICH,联合临床-影像学特征时诊断性能最佳。

要点

  • 融合模型鉴别HBM.cbh与nn-ICH的AUC为0.93(SMOTE)和0.90(无SMOTE),优于影像组学模型和临床模型。
  • 四序列全区域影像组学模型在影像组学模型中表现最佳,AUC为0.84(SMOTE)和0.83(无SMOTE)。
  • 临床模型AUC为0.71(SMOTE)和0.62(无SMOTE),单独使用临床-影像学特征鉴别能力有限。

核心结论

  • 多序列影像组学模型是鉴别HBM.cbh与nn-ICH的有效方法,联合临床-影像学特征时可获得最佳诊断性能预测模型。

研究设计与样本

  • 回顾性收集两家临床机构146例经病理或临床证实的HBM.cbh(n=55)和nn-ICH(n=91)患者数据,基于T2WI、T1WI、FLAIR和T1增强成像提取出血和/或水肿区域的影像组学特征,采用SMOTE平衡少数组,以逻辑回归和K近邻构建临床模型、影像组学模型和融合模型,并在外部数据集上用DeLong检验比较AUC。

诊断标准与关键数值

  • 四序列全区域影像组学模型AUC为0.84(SMOTE)和0.83(无SMOTE);临床模型AUC为0.71(SMOTE)和0.62(无SMOTE);融合模型AUC为0.93(SMOTE)和0.90(无SMOTE),优于影像组学模型(0.93 vs. 0.83,p<0.05;0.90 vs. 0.84,p<0.05)和临床模型(0.93 vs. 0.71,p<0.05;0.90 vs. 0.62,p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to develop and validate a fusion model combining multi-sequence MRI radiomics and clinico-radiological features to distinguish hemorrhagic brain metastasis covered by hematoma (HBM.cbh) from non-neoplastic intracranial hematomas (nn-ICH).

METHODS: The data of 146 patients with pathologically or clinically proven HBM.cbh (n = 55) and nn-ICH (n = 91) were collected from two clinical institutions. Radiomics features were extracted from various regions (hemorrhage and/or edema) based on T2-weighted, T1-weighted, fluid-attenuated inversion-recovery, and T1 contrast-enhanced imaging. Synthetic minority over-sampling technique (SMOTE) was performed to balance the minority group (HBM.cbh). Logistic regression (LR) and k-nearest neighbors (KNN) were utilized to construct the models based on clinico-radiological factors (clinical model), radiomic features from various modalities of MRI (radiomics model), and their combination (fusion model). The area under the curve (AUC) values of different models on the external dataset were compared using DeLong's test.

RESULTS: The 4-sequence radiomics model based on the entire region performed the best in all radiomics models, with or without SMOTE, where the AUCs were 0.83 and 0.84, respectively. The AUC of clinical mode was 0.71 with SMOTE, and 0.62 without SMOTE. The fusion model demonstrated excellent predictive value with or without SMOTE (AUC: 0.93 and 0.90, respectively), outperforming both the radiomics and clinical model (0.93 vs. 0.83, 0.71, p < 0.05 and 0.90 vs. 0.84, 0.62, p < 0.05, respectively).

CONCLUSIONS: The multi-sequence radiomics model is an effective method for differentiating HBM.cbh from nn-ICH. It can yield the best diagnostic performance prediction model when combined with clinico-radiological features.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Cui L, Yu L, Shao S, et al. Improving differentiation of hemorrhagic brain metastases from non-neoplastic hematomas using radiomics and clinical feature fusion. Neuroradiology. 2025. PMID: 40131431. doi:10.1007/s00234-025-03590-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。